Shaping the future of retinal therapy

Author(s) Arshad M. Khanani, MD, MA, FASRS

Advancements in drug durability and patient care are closing treatment gaps.

The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and improving clinicians’ ability to treat a variety of diseases. Even with this progress, significant gaps remain, especially regarding treatment durability.